| Immunisation | ITNs | Anti- malaria drugs | ANC | Childbirth | ARVs | FP | TB |
---|---|---|---|---|---|---|---|---|
 | Mean (SD) | Mean (SD) | Mean (SD) | Mean (SD) | Mean (SD) | Mean (SD) | Mean (SD) | Mean (SD) |
Gross benefits by urban-rural residence | ||||||||
Urban | 457.3 (140.0) | 176.2 (381.1) | 13.7 (125.8) | 81.3 (1,224.2) | 4.3 (179.4) | 0 | 0 | 14.3 (598.5) |
Rural | 419.7 (183.7) | 3.3 (57.5) | 33.7 (246.7) | 11.0 (181.1) | 10.3 (278.4) | 0 | 0 | 159.8 (2,576.3) |
Kruskal-Wallis (p-value) | 45.2 (.0001) | 278.8 (.0001) | 8.2 (.004) | 2.9 (.08) | 0.47 (.49) | - | - | 4.8 (.03) |
Gross benefits by gender | ||||||||
Males | 463.4 (130.3) | 71.9 (258.4) | 16.2 (141.5) | NA | NA | 0 | 0 | 69.1 (1,609.0) |
Females | 419.7 (183.6) | 116.5 (321.1) | 28.5 (224.9) | NA | NA | 0 | 0 | 88.1 (1,914.8) |
Kruskal-Wallis (p-value) | 60.3 (.0001) | 18.6 (.0001) | 3.2 (.07) | 18.7 (.0001) | 2.6 (.10) | - | - | 0.02 (.88) |
Gross benefits by SES | ||||||||
Quintile 1 | 398.3 (201.4) | 40.9 (198.1) | 41.4 (226.3) | 8.8 (170.6) | 11.0 (287.6) | 0 | 0 | 76.0 (1,377.3) |
Quintile 2 | 447.9 (152.9) | 83.0 (276.1) | 12.8 (124.3) | 34.4 (535.0) | 0 | 0 | 0 | 109.5 (2,134.7) |
Quintile 3 | 447.9 (152.9) | 90.8 (287.5) | 24.5 (281.9) | 55.6 (1,374.4) | 12.3 (303.2) | 0 | 0 | 164.5 (2,865.3) |
Quintile 4 | 450.1 (150.0) | 154.1 (361.3) | 19.7 (139.0) | 102.0 (1,207.9) | 12.3 (304.2) | 0 | 0 | 41.5 (1,018.1) |
Quintile 5 | 460.4 (135.2) | 124.2 (330.1) | 15.0 (134.5) | 53.5 (825.0) | 0 | 0 | 0 | 0 |
Kruskal-Wallis (p-value) | 64.5 (.0003) | 56.7 (.0001) | 15.3 (.004) | 20.3 (.0004) | 2.0 (.73) | - | - | 2.1 (.72) |
Concentration index | 0.03 | 0.19 | −0.16 | 0.25 | −0.11 | - | - | −0.22 |